Company Eastgate Biotech Corp. Other OTC
Equities
ETBI
US2772531008
Pharmaceuticals
Business Summary
Sales per Business
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Natural Compounds and Pharmaceutical Products
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Sales per region
USD in Million | 2018 | Weight | 2019 | Weight | Delta |
---|---|---|---|---|---|
Canada
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -40.43% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-14 |
William Abajian
PSD | President | 66 | 16-05-31 |
Ishaan Sundar
CTO | Chief Tech/Sci/R&D Officer | - | 17-04-11 |
Anna Gluskin
BRD | Director/Board Member | 68 | 12-05-21 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Anna Gluskin
BRD | Director/Board Member | 68 | 12-05-21 |
Rose Perri
CEO | Chief Executive Officer | 55 | 15-01-14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 717,257,377 | 717,257,377 ( 100.00 %) | 0 | 100.00 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |